Adam Brufsky to Doxorubicin
This is a "connection" page, showing publications Adam Brufsky has written about Doxorubicin.
Connection Strength
0.252
-
TITAN: phase III study of doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early-stage triple-negative breast cancer. Breast Cancer Res Treat. 2017 Aug; 164(3):649-658.
Score: 0.141
-
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103). J Clin Oncol. 2018 09 01; 36(25):2621-2629.
Score: 0.038
-
Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30. J Natl Cancer Inst. 2018 02 01; 110(2).
Score: 0.037
-
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). J Clin Oncol. 2017 Aug 10; 35(23):2647-2655.
Score: 0.035